Oculis Holding AG is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Riad Sherif, with a market cap of $1.6B.
Common questions about Oculis Holding AG
Oculis Holding AG is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $320.0K.
Oculis Holding AG has approximately 36 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.